Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Innontubilin 120mg Injection

Prescription Icon
Prescription Required

Marketer

BDR Pharmaceuticals Internationals Pvt

Salt Composition

Docetaxel (120mg)

Overview Innontubilin 120mg Injection

Tubulinase 120mg Injectable is a chemotherapy agent indicated for treating breast, non-small cell lung, prostate, and head and neck cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your specific condition and may vary. Adhere strictly to your doctor's prescribed regimen; incorrect usage or overdosage can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include shortness of breath, constipation, swelling, infections, appetite loss, myalgia, nail abnormalities, pain, and fatigue. Your doctor may prescribe additional medication to mitigate these effects. Report any unexplained bleeding or bruising, sore throat, mouth sores, or fever immediately. This medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests to monitor blood cell levels and liver function are essential. Prior to treatment, disclose any heart, liver, or kidney conditions, or concurrent medications, especially those for infections. Numerous drug interactions are possible; inform your doctor of all medications you are taking. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment.

Uses of Innontubilin 120mg Injection

Cancers of the breast, lung (non-small cell), prostate, and head and neck.

Major Benefits of Innontubilin 120mg Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Innontubilin 120mg Injection:

  • Breathlessness
  • Constipation
  • Edema (swelling)
  • Infection
  • Loss of appetite
  • Muscle pain
  • Nail disorder
  • Pain
  • Weakness

How to use Innontubilin 120mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Innontubilin 120mg Injection works:

The anti-cancer injectable drug, Innontubilin 120mg, disrupts the microtubule networks crucial for cancer cell proliferation. This disruption inhibits cancer cell growth, ultimately leading to their demise.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while using Innontubilin 120mg Injection is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Innontubilin 120mg Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits clearly outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Administering Innontubilin 120mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Innontubilin 120mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Innontubilin 120mg Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Innontubilin 120mg Injection. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Innontubilin 120mg Injection :

NA

Facts to Know About Innontubilin 120mg Injection

LabelValue
Type of Compound Taxane-based medications
Potential for Dependence None.
Type of Treatment Cancer-fighting drugs
Mechanism of Action Microtubule-targeting drugs: Taxane class

FAQs on Innontubilin 120mg Injection

Weight gain is a potential side effect of Innontubilin 120mg Injection. This can result from fluid retention, often manifesting as initial foot swelling before potentially affecting the entire body. Consult your physician promptly if you experience foot swelling.
Maintain your Innontubilin 120mg Injection regimen under your physician's guidance. Treatment length depends on your specific cancer and your response to therapy. Infusion administration is typically scheduled every three weeks.
Innontubilin 120mg Injection includes alcohol, potentially causing dizziness, drowsiness, unsteady gait, and symptoms resembling alcohol intoxication. This could compromise the safe operation of vehicles or machinery immediately following administration. Therefore, refrain from alcohol consumption while undergoing Innontubilin 120mg Injection treatment to prevent harmful interactions.
The injectable medication Innontubilin (120mg) is frequently administered in the treatment of breast cancer, specific lung cancers, prostate cancer, stomach cancer, and head and neck cancers. Its mechanism of action involves inhibiting cellular growth and proliferation.
Innontubilin 120mg Injection is administered intravenously as a liquid solution. This procedure is performed by a qualified medical professional in a clinical setting, typically over a 60-minute period, with injections scheduled at three-week intervals.
Prior to each scheduled administration of Innontubilin 120mg Injection, your physician will require blood work. This may include a complete blood count and liver function tests to assess sufficient blood cell levels and liver health for safe Innontubilin 120mg Injection use. Low white blood cell counts can lead to fever or infections.
Alopecia is a frequently reported adverse reaction associated with Innontubilin 120mg Injection. Hair regrowth typically occurs following discontinuation of Innontubilin 120mg Injection. Nevertheless, irreversible hair loss can sometimes develop. Seek medical advice if you experience any hair loss related issues.
Administration of Innontubilin 120mg Injection can lead to edema (swelling in the extremities) and serious allergic responses. Prophylactic corticosteroids (dexamethasone) are provided to all patients for three days, commencing one day before Innontubilin 120mg Injection is given, to mitigate these risks. For individuals with metastatic castration-resistant prostate cancer, dexamethasone is administered orally at 12, 3, and 1 hour prior to the Innontubilin 120mg Injection infusion.
The taxoid-class anticancer drug, Innontubilin 120mg Injection, inhibits the proliferation and metastasis of cancerous cells.
Innontubilin 120mg Inject...
8,569
MRP 10,440
17% off